Holocene Advisors, LP Astrazeneca PLC Call Options Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $5.64 Million - $6.24 Million	87,000 Added 5.82%	1,583,000 $107 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $26.1 Million - $28.3 Million	373,200 Added 33.24%	1,496,000 $107 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $70.9 Million - $80.4 Million	1,122,800 New	1,122,800 $77.9 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $29.7 Million - $36.9 Million	612,500 New	612,500 $36.7 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $16.8 Million - $19.3 Million	-316,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $13.6 Million - $17.5 Million	316,300 New	316,300 $16.7 Million

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.